These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13023101)

  • 1. The migration and oxidation-reduction activity of leukocytes from patients with acute disseminated lupus erythematosus.
    CHAUDHURI SN; MARTIN SP
    J Lab Clin Med; 1953 Jan; 41(1):108-13. PubMed ID: 13023101
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of redox activity of leukocytes as a diagnostic aid in systemic lupus erythematosus.
    COOPER CD; FELTS WR; BROWN TM; WICHELHAUSEN RH
    J Lab Clin Med; 1959 Mar; 53(3):457-67. PubMed ID: 13631329
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced glucose oxidation by leukocytes incubated with sera from patients with rheumatoid arthritis and systemic lupus erythematosus (SLE).
    Skosey JL; Sorensen LB
    J Lab Clin Med; 1971 Dec; 78(6):977. PubMed ID: 5131860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leuko-precipitins. II. Evidence of a precipitation reaction between leukocyte extracts and blood from disseminated lupus erythematosus patients].
    SELIGMANN M
    Vox Sang; 1957 Sep; 2(4):270-82. PubMed ID: 13496697
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method.
    Wenger ME; Bole GG
    J Lab Clin Med; 1973 Sep; 82(3):513-21. PubMed ID: 4728296
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-leucocyte cytoplasm, anti-leucocyte nuclei and anti-platelets in disseminated lupus erythematosis.
    DAUSSET J; COLOMBANI J; COLOMBANI M
    Nature; 1961 Sep; 191():1209-10. PubMed ID: 13719929
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases.
    DEICHER HR; HOLMAN HR; KUNKEL HG
    Arthritis Rheum; 1960 Feb; 3():1-15. PubMed ID: 13815452
    [No Abstract]   [Full Text] [Related]  

  • 8. [A pseudo-Pelger in a case of lupus erythematosus].
    WALTER F; STUTZ C
    Med Welt; 1961 Mar; 9():420-1. PubMed ID: 13782945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ultrastructural changes in peripheral blood leukocytes in lupus erythematosus].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1976 Oct; (10):3-6. PubMed ID: 1014814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Leukocyte agglutination in pyramidon agranulocytosis, lupus erythematosus and in chronic rheumatism].
    SAATHOFF J; KUSEL H
    Dtsch Arch Klin Med; 1954; 201(3):229-41. PubMed ID: 13200302
    [No Abstract]   [Full Text] [Related]  

  • 11. Inability of peripheral blood leukocytes from systemic lupus erythematosus patients to produce interferons in vitro.
    Moutsopoulos HM; Steinberg AD; Hooks JJ
    Arthritis Rheum; 1983 Apr; 26(4):575. PubMed ID: 6188471
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased oxidation of testosterone in systemic lupus erythematosus.
    Lahita RG; Kunkel HG; Bradlow HL
    Arthritis Rheum; 1983 Dec; 26(12):1517-21. PubMed ID: 6651898
    [No Abstract]   [Full Text] [Related]  

  • 13. [Unusual blood changes in acute disseminated lupus erythematosus].
    NOVOSELOVA EI
    Sov Med; 1953 Aug; 17(8):24-7. PubMed ID: 13101957
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological characteristics of acute disseminated lupus erythematosus; modifications of the electrophoretic proteinogram and lupus cells.
    MAHAUX J; DENOLIN-REUBENS R; MASCART P
    Rev Hematol; 1953; 8(1):77-87. PubMed ID: 13101092
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute disseminated lupus erythematosus.
    SISTER MARY MERCEDES
    Hosp Prog; 1952 Nov; 33(11):76; passim. PubMed ID: 12999253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Leukocytal osmotic resistance in chronic erythematosus in relation to chloroquine treatment].
    CHIEREGATO GC; BRESSANIN S
    Minerva Dermatol; 1961 Mar; 36():83-6. PubMed ID: 13693062
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Delayed" cutaneous hypersensitivity to leukocytes in disseminated lupus erythematosus.
    FRIEDMAN EA; BARDAWIL WA; MERRILL JP; HANAU C
    N Engl J Med; 1960 Mar; 262():486-91. PubMed ID: 13825102
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immuno-electrophoretic study of the blood of disseminated lupus erythematosus patients].
    SELIGMANN M; HANAU C
    Rev Hematol; 1958; 13(2):239-48. PubMed ID: 13568372
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basophils in disseminated lupus erythematosus, chronic lupus erythematosus and several dermatoses].
    Hunziker N; Brun R
    Ann Dermatol Syphiligr (Paris); 1971; 98(5):521-2. PubMed ID: 5142892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.